Clinical Trial Update: Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pomalidomide, ixazomib, and dexamethasone with or without cyclophosphamide intensification in relapsed or refractory multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Refractory Multiple Myeloma | Phase 2 | Status: COMPLETED